1. Clinical Exome Reanalysis: Current Practice and Beyond

   • Jianling Ji
   • Marco L. Leung
   • Avni Santani

   Current Opinion Open access 20 July 2021 Pages: 529 - 536

   

2. The Opportunities and Challenges of Molecular Tagging Next-Generation Sequencing in Liquid Biopsy

   • Giuseppa De Luca
   • Mariella Dono

   Current Opinion 05 July 2021 Pages: 537 - 547

   

3. Metastasis Prevention: Focus on Metastatic Circulating Tumor Cells

   • Maxim E. Menyailo
   • Ustinia A. Bokova
   • Evgeny V. Denisov

   Review Article 21 July 2021 Pages: 549 - 562

   

4. Milestones of Precision Medicine: An Innovative, Multidisciplinary Overview

   • Jesús García-Foncillas
   • Jesús Argente
   • María Vanessa Pérez Gómez

   Review Article 30 July 2021 Pages: 563 - 576

   

5. Bi-specific and Tri-specific NK Cell Engagers: The New Avenue of Targeted NK Cell Immunotherapy

   • Shee Kwan Phung
   • Jeffrey S. Miller
   • Martin Felices

   Review Article 29 July 2021 Pages: 577 - 592

   

6. Follicular T Helper and Breg Cell Balance in Severe Allergic Asthma Before and After Omalizumab Therapy

   • Laura Bergantini
   • Miriana d’Alessandro
   • Elena Bargagli

   Original Research Article Open access 03 August 2021 Pages: 593 - 605

   

7. Development and Evaluation of a Droplet Digital PCR Assay for 8p23 β-Defensin Cluster Copy Number Determination

   • Tingting Wen
   • Xianghong Zhang
   • Frank Stuber

   Original Research Article 29 July 2021 Pages: 607 - 615

   

8. Analytical and Clinical Performance of Droplet Digital PCR in the Detection and Quantification of SARS-CoV-2

   • Kyoung Bo Kim
   • Hayoung Choi
   • Myungshin Kim

   Original Research Article Open access 28 July 2021 Pages: 617 - 628

   

9. Prognostic Biomarker-Based Identification of Drugs for Managing the Treatment of Endometrial Cancer

   • Dilraj Kaur
   • Chakit Arora
   • Gajendra Pal Singh Raghava

   Original Research Article 22 June 2021 Pages: 629 - 646

   

10. Piflufolastat F 18: Diagnostic First Approval

    • Susan J. Keam

    AdisInsight Report 22 July 2021 Pages: 647 - 656